SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sogwap1 who wrote (33703)1/9/2016 11:53:15 AM
From: dorightbythem3 Recommendations

Recommended By
Fitzhughlaw
mrc758
sogwap1

  Read Replies (1) of 63284
 
Had to check what the Company said about immunotherapy in the recent past. From the Annual Report :

uk.advfn.com

Immuno-Oncology

Harnessing the patient’s own immune system to control metastatic disease has become a recent and exciting approach in cancer therapy, particularly inhibitors of programmed cell death, such as PD-1. The approval of two such agents, as well as an antibody that inhibits T lymphocyte-associated antigen 4 (“CTLA4”), has spurred interest in their combination with other therapies in order to achieve a synergism, whereby superior effects are achieved. We have begun to develop our own PD-1 antibody to evaluate its use in combination with our other anticancer agents in preclinical studies, such as the ADCs described above.

Years Behind again. I'm Disturbed, ( a natural state for me these days ) by the go it alone mentality and inability to team up with an existing more advanced program that could then generate revenue in the near term . Being taken out is not such a bad idea at this point it will save employees from having to constantly dust the shelves .

From Company Dec. 2015 Presentation, page 21 - 3 Phase III trials. Don't they understand that investors will see that and notice on page 20 where they show that there does not exist the Cash needed to run these trials. Plus no hint of a DEAL.
immunomedics.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News